/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR ▲
TEXXR

Chronicles

The story behind the story

← → days · ↑ ↓ browse · Enter similar · o open

Paris-based Aqemia, which aims to scale drug discovery using quantum physics algorithms and AI, raised a €30M Series A led by Eurazeo and Bpifrance

Patricia Allen / EU-Startups :

EU-Startups Patricia Allen

Related Coverage

Discussion

  • @eurazeo @eurazeo on x
    Eurazeo, through its Venture team, is thrilled to have led alongside @BPIFrance @aqemia's €30 million Series A funding! 💥 ➡ This #deeptech aims to design fast innovative drug candidates for dozens of critical diseases. Read more ✅ https://www.lesechos.fr/... #startup #health #ai …
  • @swipeline_media @swipeline_media on x
    🟡@aqemia, which enables biotechnology companies to complete drug development researches 10,000 times faster with its quantum-inspired technology, has nabbed €30 million. The Paris startup plans to develop its technology further with the fresh capital.